FN2 Earnings Intelligence

The Procter & Gamble Company earnings overview

Latest The Procter & Gamble Company (PG) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

Next reportThe Procter & Gamble Company reports Thursday, Jan 21, 2027 · Before market openConsensus EPS $1.85 · consensus revenue $22.82B
PG FY2027 Q1 · Calendar Q4 2026

The Procter & Gamble Company

P&G's Q1 results support the view that resilient demand and execution can sustain earnings growth: organic sales growth was volume-led and share gains broadened. The counterweight is that higher input costs and consumer sensitivity leave the durability of momentum dependent on productivity, pricing with innovation and continued execution.

EPS surprise+6.4%
Market move+5.6%
PG FY2026 Q4 · Calendar Q3 2026

The Procter & Gamble Company

The current analysis supports a cautiously constructive view of P&G's operating trajectory: share stabilization, innovation, digital tools, and retailer partnerships provide potential support, but FY2027's modest growth outlook and cost headwinds limit the strength of the near-term growth case.

EPS surprise+1.4%
Market move-1.9%
PG FY2026 Q3 · Calendar Q2 2026

The Procter & Gamble Company

P&G delivered a Q3 FY26 beat with EPS of $1.59 versus $1.56 estimated and revenue of $21.24B versus $20.53B estimated, as organic sales grew over 3% across all ten categories and seven regions. However, roughly $1 billion in after-tax cost headwinds from commodity, energy, and logistics pressures linked to Middle East geopolitical disruption are pressing margins. Management maintained FY26 guidance but now expects full-year EPS toward the lower end of the $6.83-$7.09 range. The stock saw a modest +0.92% abnormal return on the report day but drifted approximately 2.5% lower over the subsequent period, suggesting the market tempered its initial reception as the cost-pressure caveat sank in. At $148.66, the stock trades about 7% below the analyst consensus target of $159.75.

EPS surprise+1.9%
Market move+1.7%
PG FY2026 Q2 · Calendar Q1 2026

The Procter & Gamble Company

The supplied analysis supports a cautiously constructive view: P&G's resilient organic growth, maintained FY26 targets and planned innovation provide support, while U.S. demand, investment needs and execution risks leave the second-half acceleration to be demonstrated.

EPS surprise+1.1%
Market move+2.6%
PG FY2026 Q1 · Calendar Q4 2025

The Procter & Gamble Company

The supplied analysis supports a measured positive operating thesis: innovation, productivity work and growth in Greater China and Latin America are supporting demand, while competitive intensity, macro costs and restructuring execution limit confidence in the durability of that progress.

EPS surprise+4.7%
Market move+0.2%
PG FY2025 Q4 · Calendar Q3 2025

The Procter & Gamble Company

P&G’s earnings narrative remains constructive but measured: modest growth and resilient EPS are being supported by innovation, productivity and portfolio actions, while the maintained FY26 outlook reflects meaningful macro and demand constraints.

EPS surprise+4.2%
Market move-0.3%
PG FY2025 Q3 · Calendar Q2 2025

The Procter & Gamble Company

The supplied analysis supports a mixed picture: innovation, productivity and resilient margins provide support, but softer demand and a lowered outlook weaken the near-term growth case.

EPS surprise—
Market move-3.7%
PG FY2025 Q2 · Calendar Q1 2025

The Procter & Gamble Company

The supplied analysis supports a measured constructive view of P&G’s operating trajectory: broad category growth, innovation and productivity are positive signals, while improving but still-negative China sales, FX, commodities and demand uncertainty limit confidence in the durability of earnings growth.

EPS surprise—
Market move+1.9%

Get the PG recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.